(BK) The Bank of New York Mellon - Overview
Exchange: NYSE •
Country: United States •
Currency: USD •
Type: Common Stock •
ISIN: US0640581007
Stock: Banking, Custody, Investments, Wealth Management
Total Rating 48
Risk 25
Buy Signal 0.44
| Risk 5d forecast | |
|---|---|
| Volatility | 18.7% |
| Relative Tail Risk | 0.31% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 1.44 |
| Alpha | 27.78 |
| Character TTM | |
|---|---|
| Beta | 0.937 |
| Beta Downside | 1.301 |
| Drawdowns 3y | |
|---|---|
| Max DD | 17.58% |
| CAGR/Max DD | 2.47 |
EPS (Earnings per Share)
Revenue
Description: BK The Bank of New York Mellon March 04, 2026
The Bank of New York Mellon Corporation (BK) is a global financial services company. It operates through segments including Securities Services, Market and Wealth Services, Investment and Wealth Management, and Other.
The company provides a broad range of services. These include custody, trust, accounting, investment management, and wealth planning. It also offers clearing, cash management, and trading services. The asset management and custody banking sector focuses on safeguarding and managing financial assets for institutions and high-net-worth individuals.
BKs client base spans central banks, financial institutions, corporations, and high-net-worth individuals. Its business model emphasizes fee-based services rather than traditional lending, a common characteristic in the custody banking industry.
To deepen your understanding, consider researching BKs historical performance and peer comparisons on ValueRay.
Headlines to watch out for
- Global interest rate changes impact net interest income
- Custody asset growth drives fee revenue
- Regulatory compliance costs pressure profit margins
- Market volatility affects investment management fees
- Foreign exchange fluctuations influence international revenue
Piotroski VR‑10 (Strict, 0-10) 4.0
| Net Income: 5.55b TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.01 > 0.02 and ΔFCF/TA 1.28 > 1.0 |
| NWC/Revenue: -291.4% < 20% (prev -292.0%; Δ 0.57% < -1%) |
| CFO/TA 0.01 > 3% & CFO 6.73b > Net Income 5.55b |
| Net Debt (-97.64b) to EBITDA (8.36b): -11.68 < 3 |
| Current Ratio: 0.70 > 1.5 & < 3 |
| Outstanding Shares: last quarter (704.7m) vs 12m ago -3.95% < -2% |
| Gross Margin: 50.62% > 18% (prev 0.46%; Δ 5.02k% > 0.5%) |
| Asset Turnover: 8.83% > 50% (prev 9.51%; Δ -0.67% > 0%) |
| Interest Coverage Ratio: 0.25 > 6 (EBITDA TTM 8.36b / Interest Expense TTM 20.68b) |
Altman Z'' -1.08
| A: -0.24 (Total Current Assets 272.49b - Total Current Liabilities 386.86b) / Total Assets 472.30b |
| B: 0.10 (Retained Earnings 46.40b / Total Assets 472.30b) |
| C: 0.01 (EBIT TTM 5.21b / Avg Total Assets 444.18b) |
| D: 0.10 (Book Value of Equity 43.38b / Total Liabilities 427.49b) |
| Altman-Z'' Score: -1.08 = CCC |
Beneish M 1.00
| DSRI: 11.64 (Receivables 81.81b/7.08b, Revenue 39.24b/39.55b) |
| GMI: 0.91 (GM 50.62% / 45.98%) |
| AQI: 0.85 (AQ_t 0.42 / AQ_t-1 0.49) |
| SGI: 0.99 (Revenue 39.24b / 39.55b) |
| TATA: -0.00 (NI 5.55b - CFO 6.73b) / TA 472.30b) |
| Beneish M-Score: 5.56 (Cap -4..+1) = D |
What is the price of BK shares?
As of March 25, 2026, the stock is trading at USD 117.90 with a total of 3,787,450 shares traded.
Over the past week, the price has changed by +1.53%, over one month by +1.16%, over three months by +0.17% and over the past year by +42.15%.
Over the past week, the price has changed by +1.53%, over one month by +1.16%, over three months by +0.17% and over the past year by +42.15%.
Is BK a buy, sell or hold?
The Bank of New York Mellon has received a consensus analysts rating of 3.88.
Therefore, it is recommended to buy BK.
- StrongBuy: 5
- Buy: 5
- Hold: 5
- Sell: 1
- StrongSell: 0
What are the forecasts/targets for the BK price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 133.8 | 13.5% |
| Analysts Target Price | 133.8 | 13.5% |
BK Fundamental Data Overview March 22, 2026
P/E Trailing = 15.5324
P/E Forward = 13.8889
P/S = 4.0069
P/B = 2.0038
P/EG = 1.2394
Revenue TTM = 39.24b USD
EBIT TTM = 5.21b USD
EBITDA TTM = 8.36b USD
Long Term Debt = 32.30b USD (from longTermDebt, last quarter)
Short Term Debt = 2.00b USD (from shortTermDebt, last quarter)
Debt = 33.88b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = -97.64b USD (from netDebt column, last quarter)
Enterprise Value = -76.66b USD (80.15b + Debt 33.88b - CCE 190.69b)
Interest Coverage Ratio = 0.25 (Ebit TTM 5.21b / Interest Expense TTM 20.68b)
EV/FCF = -14.81x (Enterprise Value -76.66b / FCF TTM 5.18b)
FCF Yield = -6.75% (FCF TTM 5.18b / Enterprise Value -76.66b)
FCF Margin = 13.19% (FCF TTM 5.18b / Revenue TTM 39.24b)
Net Margin = 14.14% (Net Income TTM 5.55b / Revenue TTM 39.24b)
Gross Margin = 50.62% ((Revenue TTM 39.24b - Cost of Revenue TTM 19.38b) / Revenue TTM)
Gross Margin QoQ = 58.69% (prev 48.34%)
Tobins Q-Ratio = -0.16 (set to none) (Enterprise Value -76.66b / Total Assets 472.30b)
Interest Expense / Debt = 14.64% (Interest Expense 4.96b / Debt 33.88b)
Taxrate = 20.38% (376.0m / 1.84b)
NOPAT = 4.15b (EBIT 5.21b * (1 - 20.38%))
Current Ratio = 0.70 (Total Current Assets 272.49b / Total Current Liabilities 386.86b)
Debt / Equity = 0.76 (Debt 33.88b / totalStockholderEquity, last quarter 44.31b)
Debt / EBITDA = -11.68 (Net Debt -97.64b / EBITDA 8.36b)
Debt / FCF = -18.86 (Net Debt -97.64b / FCF TTM 5.18b)
Total Stockholder Equity = 43.82b (last 4 quarters mean from totalStockholderEquity)
RoA = 1.25% (Net Income 5.55b / Total Assets 472.30b)
RoE = 12.66% (Net Income TTM 5.55b / Total Stockholder Equity 43.82b)
RoCE = 6.85% (EBIT 5.21b / Capital Employed (Equity 43.82b + L.T.Debt 32.30b))
RoIC = 5.67% (NOPAT 4.15b / Invested Capital 73.25b)
WACC = 9.99% (E(80.15b)/V(114.03b) * Re(9.28%) + D(33.88b)/V(114.03b) * Rd(14.64%) * (1-Tc(0.20)))
Discount Rate = 9.28% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -100.0 | Cagr: -4.46%
[DCF] Terminal Value 62.22% ; FCFF base≈5.18b ; Y1≈3.40b ; Y5≈1.55b
[DCF] Fair Price = 175.1 (EV 22.88b - Net Debt -97.64b = Equity 120.52b / Shares 688.2m; r=9.99% [WACC]; 5y FCF grow -40.0% → 3.0% )
EPS Correlation: 93.92 | EPS CAGR: 23.59% | SUE: 2.70 | # QB: 11
Revenue Correlation: 84.69 | Revenue CAGR: 24.27% | SUE: 3.03 | # QB: 1
EPS next Quarter (2026-06-30): EPS=2.11 | Chg7d=+0.000 | Chg30d=-0.006 | Revisions Net=-1 | Analysts=9
EPS current Year (2026-12-31): EPS=8.33 | Chg7d=+0.009 | Chg30d=+0.017 | Revisions Net=+2 | Growth EPS=+11.0% | Growth Revenue=+5.4%
EPS next Year (2027-12-31): EPS=9.36 | Chg7d=+0.010 | Chg30d=+0.010 | Revisions Net=+2 | Growth EPS=+12.3% | Growth Revenue=+4.8%
[Analyst] Revisions Ratio: -1.00 (0 Up / 1 Down within 30d for Next Quarter)
[Growth] Implied Growth Rate = 2.8% (Discount Rate 9.3% - Earnings Yield 6.4%)
[Growth] Growth Spread = +2.4% (Analyst 5.3% - Implied 2.8%)
P/E Forward = 13.8889
P/S = 4.0069
P/B = 2.0038
P/EG = 1.2394
Revenue TTM = 39.24b USD
EBIT TTM = 5.21b USD
EBITDA TTM = 8.36b USD
Long Term Debt = 32.30b USD (from longTermDebt, last quarter)
Short Term Debt = 2.00b USD (from shortTermDebt, last quarter)
Debt = 33.88b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = -97.64b USD (from netDebt column, last quarter)
Enterprise Value = -76.66b USD (80.15b + Debt 33.88b - CCE 190.69b)
Interest Coverage Ratio = 0.25 (Ebit TTM 5.21b / Interest Expense TTM 20.68b)
EV/FCF = -14.81x (Enterprise Value -76.66b / FCF TTM 5.18b)
FCF Yield = -6.75% (FCF TTM 5.18b / Enterprise Value -76.66b)
FCF Margin = 13.19% (FCF TTM 5.18b / Revenue TTM 39.24b)
Net Margin = 14.14% (Net Income TTM 5.55b / Revenue TTM 39.24b)
Gross Margin = 50.62% ((Revenue TTM 39.24b - Cost of Revenue TTM 19.38b) / Revenue TTM)
Gross Margin QoQ = 58.69% (prev 48.34%)
Tobins Q-Ratio = -0.16 (set to none) (Enterprise Value -76.66b / Total Assets 472.30b)
Interest Expense / Debt = 14.64% (Interest Expense 4.96b / Debt 33.88b)
Taxrate = 20.38% (376.0m / 1.84b)
NOPAT = 4.15b (EBIT 5.21b * (1 - 20.38%))
Current Ratio = 0.70 (Total Current Assets 272.49b / Total Current Liabilities 386.86b)
Debt / Equity = 0.76 (Debt 33.88b / totalStockholderEquity, last quarter 44.31b)
Debt / EBITDA = -11.68 (Net Debt -97.64b / EBITDA 8.36b)
Debt / FCF = -18.86 (Net Debt -97.64b / FCF TTM 5.18b)
Total Stockholder Equity = 43.82b (last 4 quarters mean from totalStockholderEquity)
RoA = 1.25% (Net Income 5.55b / Total Assets 472.30b)
RoE = 12.66% (Net Income TTM 5.55b / Total Stockholder Equity 43.82b)
RoCE = 6.85% (EBIT 5.21b / Capital Employed (Equity 43.82b + L.T.Debt 32.30b))
RoIC = 5.67% (NOPAT 4.15b / Invested Capital 73.25b)
WACC = 9.99% (E(80.15b)/V(114.03b) * Re(9.28%) + D(33.88b)/V(114.03b) * Rd(14.64%) * (1-Tc(0.20)))
Discount Rate = 9.28% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -100.0 | Cagr: -4.46%
[DCF] Terminal Value 62.22% ; FCFF base≈5.18b ; Y1≈3.40b ; Y5≈1.55b
[DCF] Fair Price = 175.1 (EV 22.88b - Net Debt -97.64b = Equity 120.52b / Shares 688.2m; r=9.99% [WACC]; 5y FCF grow -40.0% → 3.0% )
EPS Correlation: 93.92 | EPS CAGR: 23.59% | SUE: 2.70 | # QB: 11
Revenue Correlation: 84.69 | Revenue CAGR: 24.27% | SUE: 3.03 | # QB: 1
EPS next Quarter (2026-06-30): EPS=2.11 | Chg7d=+0.000 | Chg30d=-0.006 | Revisions Net=-1 | Analysts=9
EPS current Year (2026-12-31): EPS=8.33 | Chg7d=+0.009 | Chg30d=+0.017 | Revisions Net=+2 | Growth EPS=+11.0% | Growth Revenue=+5.4%
EPS next Year (2027-12-31): EPS=9.36 | Chg7d=+0.010 | Chg30d=+0.010 | Revisions Net=+2 | Growth EPS=+12.3% | Growth Revenue=+4.8%
[Analyst] Revisions Ratio: -1.00 (0 Up / 1 Down within 30d for Next Quarter)
[Growth] Implied Growth Rate = 2.8% (Discount Rate 9.3% - Earnings Yield 6.4%)
[Growth] Growth Spread = +2.4% (Analyst 5.3% - Implied 2.8%)